Blog hero background graphic

Blog

The last operational mile in life sciences commercialization: Five questions you need to ask of your commercial decision system

Discover why commercialization teams miss execution windows. Explore the 5-checkpoint framework for closing the insight-to-action gap in...

The last operational mile in life sciences commercialization: Five questions you need to ask of your commercial decision systemfeatured image

Opinion: CAR Ts will only treat autoimmune diseases if we can scale delivery

When payers know the price of everything

From commercialization data foundation to launch advantage

Fast 5: Why did Merck just temper expectations for its oral PCSK9 launch?

Four strategies for winning, not just reaching, the biotech launch stage

The Space Life Sciences Podcast

Oncology confidential: candid perspectives from a 28-year oncology sales veteran

The Beghou Biopharma Review

The conference season, distilled, in this summer debrief

Threat from within: Why biopharma's drug development bottleneck is systemic

The physician feedback loop: What HCPs are telling pharma and healthcare market research

The Beghou Biopharma Review

H1’s most consequential commercialization trends; 3 questions for Star Therapeutics’ Jacob Lai

Why Medical Affairs must be integrated into field strategy

Making AI work for your first launch: Where it drives commercial and medical impact, and where it doesn't

Biopharma’s own AI myth-busters separate tall tale from truism

4 ways leading pharma teams are rethinking IC

Fast 5: MFN has reset pharma launch strategy